Akhlaghi Kalahroodi M, Loghman M, Ramezanpoor M, Shahriarirad R, Rahmanian E
J Med Case Rep. 2022; 16(1):28.
PMID: 35067227
PMC: 8784220.
DOI: 10.1186/s13256-022-03256-3.
Bo Ic B
EJIFCC. 2018; 15(3):54-57.
PMID: 29988939
PMC: 6034185.
Zhang S, Wu Z, Li J, Li P, Chen S, Wen X
Rheumatol Int. 2016; 37(4):579-584.
PMID: 27807637
DOI: 10.1007/s00296-016-3594-0.
Borut B, cucnik S, Gaspersic N, Ambrozic A, Kveder T, Rozman B
EJIFCC. 2016; 20(4):151-8.
PMID: 27683342
PMC: 4975233.
Samuelsen S, Maity A, Nybo M, Macaubas C, Lonstrup L, Balboni I
PLoS One. 2016; 11(6):e0156125.
PMID: 27257889
PMC: 4892602.
DOI: 10.1371/journal.pone.0156125.
Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome.
Zhang S, Wu Z, Chen S, Li J, Wen X, Li L
Sci Rep. 2016; 6:23839.
PMID: 27053361
PMC: 4823723.
DOI: 10.1038/srep23839.
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.
Artim-Esen B, Pericleous C, Mackie I, Ripoll V, Latchman D, Isenberg D
Arthritis Res Ther. 2015; 17:47.
PMID: 25890027
PMC: 4365552.
DOI: 10.1186/s13075-015-0568-7.
New tests to detect antiphospholipid antibodies: antiprothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies.
Sciascia S, Khamashta M, Bertolaccini M
Curr Rheumatol Rep. 2014; 16(5):415.
PMID: 24609824
DOI: 10.1007/s11926-014-0415-x.
Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
Akhter E, Shums Z, Norman G, Binder W, Fang H, Petri M
J Rheumatol. 2013; 40(3):282-6.
PMID: 23378459
PMC: 3605900.
DOI: 10.3899/jrheum.120084.
Antiphospholipid antibodies: paradigm in transition.
Horstman L, Jy W, Bidot C, Ahn Y, Kelley R, Zivadinov R
J Neuroinflammation. 2009; 6:3.
PMID: 19154576
PMC: 2640381.
DOI: 10.1186/1742-2094-6-3.
Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
Lopez L, Kobayashi K, Matsunami Y, Matsuura E
Clin Rev Allergy Immunol. 2008; 37(1):12-9.
PMID: 18982458
DOI: 10.1007/s12016-008-8096-8.
Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss.
Tebo A, Jaskowski T, Hill H, Branch D
Clin Exp Immunol. 2008; 154(3):332-8.
PMID: 18826497
PMC: 2633231.
DOI: 10.1111/j.1365-2249.2008.03774.x.
Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P
Clin Rheumatol. 2007; 26(10):1663-70.
PMID: 17332980
DOI: 10.1007/s10067-007-0566-5.
Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.
Yang Y, Hwang K, FitzGerald J, Grossman J, Taylor M, Hahn B
J Immunol. 2006; 177(11):8219-25.
PMID: 17114499
PMC: 1950736.
DOI: 10.4049/jimmunol.177.11.8219.
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene.
Jacobsen E, Trettenes E, Wisloff F, Abildgaard U
Thromb J. 2006; 4:3.
PMID: 16436199
PMC: 1368967.
DOI: 10.1186/1477-9560-4-3.
Gene-expression patterns predict phenotypes of immune-mediated thrombosis.
Potti A, Bild A, Dressman H, Lewis D, Nevins J, Ortel T
Blood. 2005; 107(4):1391-6.
PMID: 16263789
PMC: 1895419.
DOI: 10.1182/blood-2005-07-2669.
Clinical and laboratory characteristics of drug-induced vasculitic syndromes.
Wiik A
Arthritis Res Ther. 2005; 7(5):191-2.
PMID: 16207347
PMC: 1257446.
DOI: 10.1186/ar1805.
IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
Locht H, Wiik A
Clin Rheumatol. 2005; 25(2):246-50.
PMID: 16177835
DOI: 10.1007/s10067-005-1166-x.
Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.
Dupuy dAngeac A, Stefas I, Graafland H, De Lamotte F, Rucheton M, Palais C
Biochem J. 2005; 393(Pt 1):117-27.
PMID: 16097953
PMC: 1383670.
DOI: 10.1042/BJ20050932.
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.
Uthman I, Khamashta M
Ann Rheum Dis. 2005; 64(12):1671-6.
PMID: 15919676
PMC: 1755326.
DOI: 10.1136/ard.2005.038448.
